BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38383240)

  • 1. Blood-based liquid biopsy: A promising noninvasive test in diagnosis, surveillance, and prognosis of patients with upper tract urothelial carcinoma.
    Ghoreifi A; Shishido SN; Sayeed S; Courcoubetis G; Huang A; Schuckman A; Aron M; Desai M; Daneshmand S; Gill IS; Kuhn P; Djaladat H; Mason J
    Urol Oncol; 2024 Apr; 42(4):118.e9-118.e17. PubMed ID: 38383240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid Biopsy Landscape in Patients with Primary Upper Tract Urothelial Carcinoma.
    Shishido SN; Ghoreifi A; Sayeed S; Courcoubetis G; Huang A; Ye B; Mrutyunjaya S; Gill IS; Kuhn P; Mason J; Djaladat H
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Liquid-Biopsy-Based Biomarkers in Upper Tract Urothelial Carcinoma.
    Padullés B; Carrasco R; Ingelmo-Torres M; Roldán FL; Gómez A; Vélez E; Alfambra H; Figueras M; Carrion A; Gil-Vernet J; Mengual L; Izquierdo L; Alcaraz A
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsies for detection, surveillance, and prognosis of urothelial cancer: a future standard?
    Duquesne I; Abou Chakra M; Hage L; Pinar U; Loriot Y
    Expert Rev Anticancer Ther; 2023; 23(9):995-1007. PubMed ID: 37542214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of previous malignancy at diagnosis on oncological outcomes of upper tract urothelial carcinoma.
    Zhao H; Liu K; Giannakopoulos S; Yuruk E; De Naeyer G; Álvarez-Maestro M; Ng CF; Laguna P; De La Rosette J; Yuen-Chun Teoh J
    BMC Urol; 2023 Mar; 23(1):49. PubMed ID: 36991375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.
    Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R
    Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusive Ki67 and vimentin are associated with worse recurrence-free survival of upper tract urothelial carcinoma: A retrospective cohort study from bench to bedside.
    Yang CH; Weng WC; Ou YC; Lin YS; Huang LH; Lu CH; Tsao TY; Hsu CY; Tung MC
    Urol Oncol; 2022 Mar; 40(3):109.e21-109.e30. PubMed ID: 34750051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-specific targeted analysis of circulating tumour DNA in plasma is feasible and may be a potential biomarker in UTUC.
    Mu N; Jylhä C; Axelsson T; Sydén F; Brehmer M; Tham E
    World J Urol; 2023 Dec; 41(12):3421-3427. PubMed ID: 37721600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
    Chen H; Wang M; Weng T; Wei Y; Yang L; Ren K; Tang Z; Gou X
    Urol Int; 2022; 106(2):186-194. PubMed ID: 34492655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial Carcinoma.
    Huelster HL; Gould B; Schiftan EA; Camperlengo L; Davaro F; Rose KM; Soupir AC; Jia S; Zheng T; Sexton WJ; Pow-Sang J; Spiess PE; Daniel Grass G; Wang L; Wang X; Vosoughi A; Necchi A; Meeks JJ; Faltas BM; Du P; Li R
    Eur Urol; 2024 Mar; 85(3):283-292. PubMed ID: 37802683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management.
    Naser-Tavakolian A; Ghodoussipour S; Djaladat H
    Curr Opin Urol; 2019 May; 29(3):189-197. PubMed ID: 30762673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma.
    Ehdaie B; Furberg H; Zabor EC; Ostroff JS; Shariat SF; Bochner BH; Coleman JA; Dalbagni G
    BJU Int; 2013 Apr; 111(4):589-95. PubMed ID: 22642265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer.
    Xie J; Zhang XB; Wen J; Zhang YS; Li HZ
    Int Urol Nephrol; 2016 Apr; 48(4):481-7. PubMed ID: 26797856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.
    Bree KK; Hensley PJ; Brooks NA; Matulay J; Li R; Nogueras Gonzalez GM; Navai N; Grossman HB; Matin SF; Dinney CPN; Kamat AM
    BJU Int; 2021 Nov; 128(5):568-574. PubMed ID: 33484074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic Management of Upper Urinary Tract Urothelial Carcinoma: Oncologic Outcomes and Prognostic Factors in a Contemporary Cohort.
    Sanguedolce F; Fontana M; Turco M; Territo A; Lucena JB; Cortez JC; Vanacore D; Meneghetti I; Gallioli A; Gaya JM; Redorta JP; Breda A
    J Endourol; 2021 Nov; 35(11):1593-1600. PubMed ID: 33971725
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of tumor architecture on disease recurrence and cancer-specific mortality of upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Fan B; Hu B; Yuan Q; Wen S; Liu T; Bai S; Qi X; Wang X; Yang D; Sun X; Song X
    Tumour Biol; 2017 Jul; 39(7):1010428317710822. PubMed ID: 28714362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Operative management in patients with upper tract urothelial carcinoma in Iceland: a population-based study.
    Björnsson O; Jónsson E; Guðmundsson EO; Marteinsson VÞ; Nikulásson SÞ; Guðjónsson S
    Scand J Urol; 2021 Jun; 55(3):197-202. PubMed ID: 33913379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma.
    Tamura D; Abe M; Hiraki H; Sasaki N; Yashima-Abo A; Ikarashi D; Kato R; Kato Y; Maekawa S; Kanehira M; Takata R; Maejima K; Sasagawa S; Fujita M; Suzuki Y; Nakagawa H; Iwaya T; Nishizuka SS; Obara W
    Cancer Sci; 2024 Feb; 115(2):529-539. PubMed ID: 38083992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.